| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.31B | 39.36B | 35.03B | 31.01B | 26.42B | 21.34B |
| Gross Profit | 24.76B | 26.94B | 23.84B | 20.94B | 17.93B | 14.59B |
| EBITDA | 3.07B | 3.92B | 2.80B | 2.18B | 1.28B | -137.68M |
| Net Income | 1.47B | 1.62B | 1.36B | 909.59M | 886.15M | 1.19B |
Balance Sheet | ||||||
| Total Assets | 24.85B | 27.12B | 25.30B | 24.94B | 24.16B | 24.16B |
| Cash, Cash Equivalents and Short-Term Investments | 5.25B | 5.73B | 6.34B | 8.01B | 10.73B | 11.57B |
| Total Debt | 1.72B | 603.12M | 1.92B | 2.74B | 3.87B | 4.88B |
| Total Liabilities | 6.78B | 7.27B | 7.47B | 8.13B | 8.22B | 9.11B |
| Stockholders Equity | 18.07B | 19.66B | 17.82B | 16.82B | 15.94B | 15.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 454.87M | -515.88M | 582.09M | 372.09M | 2.37B |
| Operating Cash Flow | 0.00 | 3.72B | 2.22B | 2.46B | 1.73B | 3.01B |
| Investing Cash Flow | 0.00 | -3.36B | -2.67B | -3.83B | -1.41B | -708.77M |
| Financing Cash Flow | 0.00 | -1.61B | -1.23B | -1.35B | -1.17B | 1.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | ¥52.18B | 33.97 | ― | 0.53% | 12.35% | 19.52% | |
63 Neutral | ¥51.65B | 31.42 | ― | 1.30% | 2.40% | -26.93% | |
63 Neutral | ¥36.93B | 9.42 | ― | 1.04% | 5.13% | 16.50% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥54.07B | 15.70 | ― | 0.56% | 2.94% | 78.37% | |
59 Neutral | ¥53.44B | 40.19 | ― | 0.17% | 17.94% | 0.67% | |
51 Neutral | ¥47.25B | 14.55 | ― | 2.41% | 9.25% | -29.60% |